- Home
- INM vs TCRT Comparison
INM vs TCRT Comparison
Compare INM & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- TCRT
- Stock Information
- Founded
- INM 1981
- TCRT 1998
- Country
- INM Canada
- TCRT United States
- Employees
- INM N/A
- TCRT N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- TCRT Biotechnology: Pharmaceutical Preparations
- Sector
- INM Health Care
- TCRT Health Care
- Exchange
- INM Nasdaq
- TCRT Nasdaq
- Market Cap
- INM 2.3M
- TCRT 2.6M
- IPO Year
- INM N/A
- TCRT N/A
- Fundamental
- Price
- INM $3.12
- TCRT $1.68
- Analyst Decision
- INM
- TCRT
- Analyst Count
- INM 0
- TCRT 0
- Target Price
- INM N/A
- TCRT N/A
- AVG Volume (30 Days)
- INM 84.1K
- TCRT 12.3K
- Earning Date
- INM 02-12-2025
- TCRT 03-31-2025
- Dividend Yield
- INM N/A
- TCRT N/A
- EPS Growth
- INM N/A
- TCRT N/A
- EPS
- INM N/A
- TCRT N/A
- Revenue
- INM $4,832,013.00
- TCRT $7,000.00
- Revenue This Year
- INM N/A
- TCRT N/A
- Revenue Next Year
- INM N/A
- TCRT N/A
- P/E Ratio
- INM N/A
- TCRT N/A
- Revenue Growth
- INM N/A
- TCRT N/A
- 52 Week Low
- INM $2.42
- TCRT $1.50
- 52 Week High
- INM $15.70
- TCRT $26.00
- Technical
- Relative Strength Index (RSI)
- INM 37.82
- TCRT 48.71
- Support Level
- INM $3.03
- TCRT $1.59
- Resistance Level
- INM $3.48
- TCRT $1.70
- Average True Range (ATR)
- INM 0.20
- TCRT 0.09
- MACD
- INM 0.05
- TCRT 0.01
- Stochastic Oscillator
- INM 35.59
- TCRT 69.23
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations.